Volpara Health Technologies Limited (VHT.XA)
| Previous close | 1.1450 |
| Open | 1.1425 |
| Bid | 1.1450 x N/A |
| Ask | 1.1500 x N/A |
| Day's range | 1.1425 - 1.1450 |
| 52-week range | 0.6050 - 1.1450 |
| Volume | |
| Avg. volume | 257,178 |
| Market cap | N/A |
| Beta (5Y monthly) | 1.67 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.0590 |
| Earnings date | 21 May 2024 - 25 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
PR NewswireDiagnostic Imaging for Women Enhances Mammography Quality with AI: Results Presented at ASMIRT 2024
At the Australian Society of Medical Imaging and Radiation Therapy (ASMIRT) conference this week in Darwin, Diagnostic Imaging for Women (difw), together with Volpara Health announced significant advancements in applying AI to mammography quality assurance. Over a 12-month period, the application of Volpara Analytics™ AI software markedly improved both diagnostic accuracy and operational efficiency at difw, Brisbane's premier tertiary women's imaging centre.
Business WireVolpara Health Appoints Clarity Quest as Agency of Record
GROTON, Conn., May 09, 2024--Volpara Health, a global leader in early detection & prevention of cancer, announced that it has selected Clarity Quest as its agency of record.
PR NewswireVolpara Launches MQSA Compliance Software at the Society for Breast Imaging Symposium
Volpara Health Technologies Ltd. (ASX: VHT), a global leader in software for the early detection and prevention of cancer, today debuted a new central, digital destination to manage mammography systems, staff credentials and professional development in support of compliance with the Food & Drug Administration's Mammography Quality Standards Act (MQSA). Volpara® Quiver™ software is featured at the Society for Breast Imaging's (SBI) annual symposium alongside the company's suite of solutions for a
